Human malignant neoplasms not infrequently reveal mononuclear cell infiltrates which have features in common with immune-associated inflammatory reactions (Underwood, 1974) . Although there is limited evidence for tumourrelated functional activity in the infiltrating leucocyte compartment (see Haskill, 1983), the relationship of the phenomenon at a functional or histological level to biological behaviour remains largely obscure.
Summary The reactivity of murine monoclonal antibodies (McAbs) directed against the monomorphic determinants of Class I and Class II antigens of the major histocompatibility complex (MHC), and against antigens expressed by discrete populations of leucocytes was studied using the indirect immunoperoxidase technique on serial tissue sections of 16 benign and 17 malignant primary human breast tumours. Class I antigens (detected by the McAb 2AI) were consistently associated with stromal leucocytes, fibroblasts and vascular endothelium, but expression on epithelial cells particularly of malignant provenance, was more variable. Class II antigens (detected by TDR 31.1) were present upon a variety of cell types which also included sporadic expression on malignant and benign epithelia. The distribution of leucocytes grossly monitored with 2D1 (reactive with a common leucocyte antigen) was largely interepithelial and periductal in benign lesions. Leucocytes were generally more numerous in malignant tumours, where they were largely confined to the stroma. The majority (-75%) of leucocytes were T lymphocytes (reactive with UCHT1), some of which appeared to react with TDR 31.1 and were therefore activated. Ratios of helper/inducer (OKT4+) and suppressor/cytotoxic (OKT8+) subsets generally exceeded unity in malignant neoplasms. There was no correlation between the extent and distribution of T cells and the HLA status of the epithelial cells. Leucocytes detected by the monoclonal antibody OKM 1 which reacts with monocytes/macrophages, granulocytes and large granular lymphocytes were numerically few and again mainly confined to the stroma. In a limited number of tests, leucocytes detected with HNK1, reactive with a differentiation antigen expressed on some cells which mediate natural and antibody-dependent cellular cytotoxicity in vitro although detectable interepithelially in benign tumours, were virtually absent from malignant tissue. HNK1 also cross-reacted with myoepithelial cells in the ducts of benign lesions.
Human malignant neoplasms not infrequently reveal mononuclear cell infiltrates which have features in common with immune-associated inflammatory reactions (Underwood, 1974) . Although there is limited evidence for tumourrelated functional activity in the infiltrating leucocyte compartment (see Haskill, 1983) , the relationship of the phenomenon at a functional or histological level to biological behaviour remains largely obscure.
The majority of solid human neoplasms are characterised by marked cellular heterogeneity and any provisional assignment of in situ function will require the elucidation of the heterogeneity and microanatomical distribution of potential leucocytic effector cells relative to the tumour population. Such an analysis must also extend to the neoplastic (Woodruff, 1983) and although several useful markers exist (Lennox & Sikora, 1982 ) the antigens which evoke cellular immune responses have not been serologically defined.
The initiation of the present study coincided with reports of heterogeneity of expression of Class I (Fleming et al., 1981) and anomalous expression of Class II (DR) antigens (Natali et al., 1981a; Daar et al., 1982) of the major histocompatibility complex (MHC) on primary human tumours. Since these MHC products have a crucial role in cell:cell interactions involving both the inductive and effector phases of the immune response it seemed reasonable to examine, as a preliminary approach, the HLA status of primary tumours in conjunction with leucocyte infiltration. For this purpose we have deployed the indirect immunoperoxidase technique using monoclonal antibodies (McAbs) against the major leucocyte populations and their subsets and McAbs to the monomorphic determinants of the HLA Class I and Class II antigens. Breast was the tissue of choice on account of the availability of benign and malignant tissue from the same organ and the absence of infection.
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Monoclonal antibodies
The following murine McAbs were used in this study:
2AI IgGI antibody identifying human HLA Class I (HLA-A, B, C) non-polymorphic determinant (Beverley, 1980 (Kung et al., 1979) .
OKT4 IgG2b antibody reactive with 62K dalton mol.wt. antigen expressed on human T cells of helper/inducer subclass (TH2 -T cells) (Kung et al., 1979; Reinherz et al., 1979a, b) .
OKT8 IgG2a antibody reactive with an undefined antigen of peripheral T cells of cytotoxic/suppressor subclass (TH2 +) . OKMI IgG2b antibody reactive with mature monocytes, granulocytes and certain circulating null cells (Breard et al., 1980) including cells which mediate NK activity (Zarling & and antibody-dependent cellular cytotoxicity (Kay & Horowitz, 1980) .
HNK-1 IgM antibody (Leu 7) which defines a differentiation antigen selectively expressed on NK and antibody-dependent killer (K) cells (Abo & Balch, 1981 Tables I and II. 2A1 ( (Figure 4 ). Round cell staining was a more frequent and prominent feature of malignant than benign tissue and not, by contrast with the latter, principally found in association with ducts. Positive cells were characteristically found in the stroma surrounding tumour foci, with relatively few actually detectable within the tumour mass ( Figure 5 ). There appeared to be no correlation between the extent and distribution of 2DI staining and necrosis. UCHTI (anti pan T cell) Staining patterns observed with UCHT1 were of macrophages were most obvious in and around dilated ducts (Figure 11 ). In malignant tumours, staining from virtually none at all to clusters of cells again resembling macrophages were almost invariably confined to the stroma (Figure 12) Selective absorption from plasma of HLA Class I antigens on to the surface of epithelial cells, or masking by circulating antibody to Class I molecules are not adequate explanations of the inter-and intra-tumour variation observed with 2A1, although subtle undefined conformational changes in the monomorphic determinant which might render it unreactive with the monoclonal antibody could conceivably occur. The data rather suggest that the expression of HLA Class I molecules in a major group of primary malignant breast tumours is reduced.
The reduction of HLA Class I antigens or their heterogeneous distribution within a neoplasm may have important biological implications e.g. for the associative recognition of tumour antigens by T cells and hence for immunosurveillance.
However, there was no apparent qualitative or quantitative correlation between leucocyte infiltration and HLA Class I antigen expression. In this report our data contrast with recent experience with dysplastic and malignant nevomelanocytes where the degree of mononuclear cell infiltration correlated with the expression of HLA (or f2 microglobulin) on nevomelanocytes (Ruiter et al., 1982) .
Staining with the anti HLA-DR McAb (TDR31.1) also comprised lymphoid and nonlymphoid cells. The numbers of leucocytes stained were usually less than those stained with either 2D1 or UCHT1, suggesting that not all the tumourassociated T cells were DR+. However, the extent of T cell activation by this criterion alone is difficult to assess since an anti HLA-DR McAb would also be expected to strain the minority (-25% leucocytes) B cell and monocyte/macrophage populations. The deployment of the Tac monoclonal antibody to the IL-2 receptor on activated T cells (Uchiyama et al., 1981) might resolve the issue. The variability of expression of HLA-DR on epithelial cells is consistent with previous immunohistological studies of these antigens on human bronchial, intestinal and mammary epithelia (Natali et al., 1981b) , where extrinsic factors such as hormonal changes associated with pregnancy and lactation (Klareskog et al., 1980) and the development of graft versus host disease (Lampert et al., 1981; Mason et al., 1981) are influential. The anomalous expression of HLA-DR antigens on solid human tumours is of comparatively more recent description (Natali et al., 1981a; Gatter et al., 1982; Daar et al., 1982; Daar & Fabre, 1983) . Several other cell types involved in immune and inflammatory processes also express Ia antigens Hammerling, 1976) , but the mechanism(s) of induction is largely unknown. Since la antigens are important in cell:cell interactions and in antigen presentation (Lonai et al., 1981) , the expression of similar molecules on tumour cells could have implications for the induction of immune responses to putative tumourassociated antigens. However, why this should be a property of only some tumour cells (including those of benign origin) requires further investigation.
Staining with the antibodies 2D1, UCHTI, OKT4, OKT8 and MAS020 disclosed two features which differed in malignant tumours from those in benign tumours. First, leucocyte infiltration although variable, was generally more intense. Second, the microanatomical distribution of the leucocytes differed insofar as they were principally to be found surrounding foci of malignant cells as distinct from being largely confined to the ducts in benign tumours. In other respects there was little distinction between benign and malignant tissues; the infiltrative leucocytes were predominantly (-75%) T cells and the subset (OKT4/OKT8) ratios of the order of those reported for peripheral blood (McCluskey et al., 1983) . However, in some tumours there appeared to be a shift toward the suppressor/cytotoxic subset.
Other leucocytes were monitored by the monoclonal antibodies OKM1 and HNK1. Immunofluorescence flow cytometry data have shown that OKM1 is reactive with peripheral blood monocytes, granulocytes and a major proportion of circulating NK cells (large granular lymphocytes) (Ortaldo et al., 1981) . Although in positively stained sections, not all cells could be unequivocally identified without recourse to double-labelling techniques, macrophages appeared to be the predominant cell type. The presence of OKM1+ cells in the ducts is consistent with macrophages being a component of the interepithelial leucocyte population of the human mammary gland and also accounts for the detection of similar cells in the alveolar lumina (Selig & Beer, 1981) .
The OKM 1+ cells present in the leucocyte infiltrates of the malignant tumours were also morphologically consistent with macrophages, though staining of large granular lymphocytes could not be ruled out solely on these grounds. OKM1+ cells were numerically fewer than T cells recognised by the UCHT1 antibody and were thus a minority component of all the infiltrates. There was no clear numerical or microanatomical relationship between OKT4+ (T helper) and OKM1+ cells. In common with T cells, OKM1+ cells were mostly confined to the stromal reaction; relatively few had penetrated tumour foci. Functional data on recovered macrophages attributing them with an in vivo cytotoxic role should be interpreted in this awareness.
Although in this study relatively few sections were stained with the monoclonal antibody HNK1, two points of interest emerged. The positive cells in benign sections corresponded largely to ductal interepithelial leucocytes and by contrast with the other monoclonal antibodies used here, there was consistent staining of myoepithelial cells. The significance of this cross-reactivity and the relationship between HNK1 and other markers of myoepithelial cells (Bussolati et al., 1983 ) is unknown. The second observation was the virtual absence of HNK1 + cells from the 3 malignant tumours which were examined. HNK1+ cells are heterogeneous, but since a proportion express T cell markers (Abo et al., 1982a) , this observation is somewhat surprising and could point to some selectivity in extravasation. It should not, however, be taken to indicate that there are no NK cells in breast cancers since not all NK/K cells react with HNK1 ( Abo, 1982b) . Even so, there are likely to be few: since up to 60% of HNK1 + cells are also OKM1+ (Abo et al., 1982a) it would appear that most of the OKM1 + cells in the tumours are macrophages. This conclusion accords with functional studies conducted with lymphoid cells recovered from freshly disaggregated neoplasms wherein breast, in common with other solid tumours has generally disclosed low or non-existent levels of NK activity, (Vose et al., 1977; Totterman et al., 1978; Moore & Vose, 1981; Eremin et al., 1981; Introna et al., 1983) . The recent availability of McAbs with greater selectivity for NK cells should allow further examination of this question (Perussia et al., 1983a, b 
